Shortage crisis drives temporary importation, quick OK of cancer drugs
This article was originally published in Scrip
Executive Summary
With the drumbeat growing ever louder about the problem of patients unable to access critical life-saving drugs, FDA Commissioner Dr Margaret Hamburg used her regulatory authority to temporarily permit Indian drug maker Sun Pharma to import its ovarian cancer and multiple myeloma medicine Lipodox (doxorubicin hydrochloride liposome injection) into the US, even though the product is not approved for marketing by the agency, to fill the shortage of Janssen Products' Doxil, which contains the same active ingredient.
You may also be interested in...
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Clinton's Drug Price Plan: Threat Or Flash In The Political Pan?
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.